By King & Wood Mallesons’ Compliance Group

On March 7th, 2014, the State Council issued the Regulation on the Supervision and Administration of Medical Devices (“Regulation”). On July 30th, 2014, China Food and Drug Administration issued the Measures for the Management, Supervision and Administration over Retail of Medical Devices (“Measure”). On December 12th, 2014, China Food and Drug Administration issued the Standards for Quality Control of Medical Devices (“Standard”). The series of regulatory actions demonstrates China’s efforts to strengthen administration of manufacturers and retailers of medical devices and equipment.
Continue Reading Medical Devices production enterprises are facing higher supervision

By Kalley Chen  King & Wood Mallesons’ Securities Group

To address China’s aging population issue as well as its need to improve access to healthcare in rural areas, healthcare reform has become a priority for the Chinese government.

A key mechanism to improve access is through the promotion of private healthcare. While current exit restrictions exist in relation to private medical institutions, recent policy developments which have liberalized investment in the healthcare sector demonstrate China’s progress toward improving healthcare. It is likely that these policies may stimulate greater PE investment opportunities, in particular within the private healthcare sector.
Continue Reading The promotion of private healthcare services- A Challenge or an opportunity?